Elena Ambrosini

Dr. Elena Ambrosini

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2004 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
EAElena Ambrosini
Elena Ambrosini
FAFrancesca Aloisi
Francesca Aloisi

1 August 2005 in Journal of Neuropathology & Experimental Neurology
Verified
Journal Article
Open access
PDF file
EAElena Ambrosini
Elena Ambrosini
MRMaria Elena Remoli
Maria Elena Remoli
EGElena Giacomini
Elena Giacomini
BRBarbara Rosicarelli
Barbara Rosicarelli
Barbara SerafiniBarbara Serafini
Barbara Serafini
ECEliana Coccia
Eliana Coccia
As a result of their close association with the blood-brain barrier, astrocytes play an important role in regulating the homing of different leukocyt

18 January 2005 in Glia
Verified
Journal Article
Closed access
PDF file
CAC. Agresti
C. Agresti
MMM.E. Meomartini
M.E. Meomartini
SAsusanna amadio
susanna amadio
EAElena Ambrosini
Elena Ambrosini
Barbara SerafiniBarbara Serafini
Barbara Serafini
SVSergio Visentin
Sergio Visentin

1 April 2005 in Brain Research Reviews
Verified
Journal Article
Closed access
CAC. Agresti
C. Agresti
MMM.E. Meomartini
M.E. Meomartini
SAsusanna amadio
susanna amadio
EAElena Ambrosini
Elena Ambrosini
Cinzia VolontéCinzia Volonté
Cinzia Volonté
SVSergio Visentin
Sergio Visentin

8 January 2003 in Glia
Verified
Journal Article
Closed access
PDF file
EAElena Ambrosini
Elena Ambrosini
SCSandra Columba‐Cabezas
Sandra Columba‐Cabezas
Barbara SerafiniBarbara Serafini
Barbara Serafini
AMAntonella Muscella
Antonella Muscella
FAFrancesca Aloisi
Francesca Aloisi

28 September 2016 in Scientific Reports
Verified
Journal Article
Open access
PDF file
FSFederico Sicca
Federico Sicca
EAElena Ambrosini
Elena Ambrosini
MMMaria Marchese
Maria Marchese
LSLUIGI SFORNA
LUIGI SFORNA
ISIlenio Servettini
Ilenio Servettini
MPMauro Pessia
Mauro Pessia
Dysfunction of the inwardly-rectifying potassium channels Kir4.1 (KCNJ10) represents a pathogenic mechanism contributing to Autism-Epilepsy comorbidity. To define the role of Kir4.1 variants in the disorder, we sequenced KCNJ10 in a sample of affected individuals and performed genotype-phenotype correlations. The effects of mutations on channel activity, protein trafficking and astrocyte function were investigated in Xenopus laevis oocytes and in human astrocytoma cell lines. An in vivo model of the disorder was also explored through generation of kcnj10a morphant zebrafish overexpressing the mutated human KCNJ10. We detected germline heterozygous KCNJ10 variants in 19/175 affected children. Epileptic spasms with dysregulated sensory processing represented the main disease phenotype. When investigated on astrocyte-like cells, the p.R18Q mutation exerted a gain-of-function effect by enhancing Kir4.1 membrane expression and current density. Similarly, the p.R348H variant led to gain of channel function through hindrance of pH-dependent current inhibition. The frequent polymorphism p.R271C seemed, instead, to have no obvious functional effects. Our results confirm that variants in KCNJ10 deserve attention in autism-epilepsy and provide insight into the molecular mechanisms of autism and seizures. Similar to neurons, astrocyte dysfunction may result in abnormal synaptic transmission and electrical discharge and should be regarded as a possible pharmacological target in autism-epilepsy.